RecruitingNot ApplicableNCT05989477

At-home Breast Oncology Care Delivered With E-health Solutions

At-home Breast Oncology Care Delivered With E-health Solutions The ABODE Study


Sponsor

University Health Network, Toronto

Enrollment

200 participants

Start Date

Jun 22, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The COVID-19 pandemic has significantly impacted healthcare service delivery, highlighting the need for high quality virtual patient care. Our team has developed a multi-dimensional remote eHealth solution for newly diagnosed breast cancer patients and their practitioners to use during the diagnostic and follow-up period. The ABODE study involved development of a Breast Cancer Treatment Application (app) which will facilitate virtual consultations, deliver patient education material, and collect patient reported outcome measures (PROMs). Using a randomized controlled trial design, the team will evaluate a variety of outcomes for breast cancer patients who will use the app throughout their diagnosis and treatment period. Primary Objective: To compare changes in patient activation (assessed by PAM-13) over 1 year among newly diagnosed breast cancer patients between those using the app and those receiving standard care. Secondary Objectives: 1. Compare additional PROMs between the standard care and intervention groups 2. Describe health service outcomes among app users 3. Explore end-user experience of using the app 4. Measure activity levels using wearable devices


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria6

  • Females (assigned female at birth)\*
  • Diagnosed with first, primary invasive BC
  • Must have surgery as their first step in treatment pathway
  • Age≥18
  • Access to an electronic device with connection to the internet
  • A valid email address

Exclusion Criteria7

  • Males (assigned male at birth), as BC surgical treatment options and experiences are different
  • Diagnosed with non-operable breast cancer
  • Stage 4/metastatic (whether determined at diagnosis or during surgery)
  • Those with hearing or visual challenges
  • Neo-adjuvant chemotherapy
  • Should not be enrolled in any other UHN study using an e-Health application
  • Breast cancer surgery is scheduled for less 5 business days after enrollment

Interventions

OTHERAt-home Breast Oncology care Delivered with E-health solutions - ABODE

The development and implementation of the Breast Cancer Treatment Application (BCTA) will facilitate a secure approach to virtual care for Breast Cancer patients, provide patient specific treatment education and facilitate evaluation of Patient Reported Outcome Measures.


Locations(1)

Tulin Cil

Toronto, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05989477


Related Trials